GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xebra Brands Ltd (XCNQ:XBRA) » Definitions » EPS (Diluted)

Xebra Brands (XCNQ:XBRA) EPS (Diluted) : C$-0.04 (TTM As of Aug. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xebra Brands EPS (Diluted)?

Xebra Brands's Earnings per Share (Diluted) for the three months ended in Aug. 2024 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was C$-0.04.

Xebra Brands's EPS (Basic) for the three months ended in Aug. 2024 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2024 was C$-0.04.

Xebra Brands's EPS without NRI for the three months ended in Aug. 2024 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2024 was C$-0.03.

During the past 3 years, the average EPS without NRIGrowth Rate was 31.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Xebra Brands's highest 3-Year average EPS without NRI Growth Rate was 31.20% per year. The lowest was -0.90% per year. And the median was 15.15% per year.


Xebra Brands EPS (Diluted) Historical Data

The historical data trend for Xebra Brands's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xebra Brands EPS (Diluted) Chart

Xebra Brands Annual Data
Trend Feb20 Feb21 Feb22 Feb23 Feb24
EPS (Diluted)
-0.13 -0.09 -0.25 -0.10 -0.04

Xebra Brands Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.02 -0.01 -0.01

Competitive Comparison of Xebra Brands's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Xebra Brands's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xebra Brands's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xebra Brands's PE Ratio distribution charts can be found below:

* The bar in red indicates where Xebra Brands's PE Ratio falls into.



Xebra Brands EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Xebra Brands's Diluted EPS for the fiscal year that ended in Feb. 2024 is calculated as

Diluted EPS (A: Feb. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.957-0)/54.236
=-0.04

Xebra Brands's Diluted EPS for the quarter that ended in Aug. 2024 is calculated as

Diluted EPS (Q: Aug. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.384-0)/73.793
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xebra Brands  (XCNQ:XBRA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Xebra Brands EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Xebra Brands's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Xebra Brands Business Description

Traded in Other Exchanges
Address
410-1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
Xebra Brands Ltd is engaged in the processing, manufacturing, design and delivery of cannabis products in areas ranging from wellness to leisure.
Executives
Antonio Grimaldo Monroy Director

Xebra Brands Headlines

No Headlines